Lustgarten Andrew
Lustgarten Andrew's purchase track record
Lustgarten Andrew has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/4/2022 | MSGS | $996K | +0.4% | -3.5% | -9.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Guggenheim lowers Sphere Entertainment price target to $180. Guggenheim has lowered its price target for Sphere Entertainment to $180 while maintaining a Buy rating. This update places the firm's estimate within the broader analyst consensus range of $125 to $200. The stock is currently trading near its 52-week low, reflecting recent market pressure despite the firm's continued positive outlook.
Transaction History
| MSGS | ▲ Buy | Option Exercise | 11,296 | $0 | 11/27/2024 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 2,188 | $0 | 11/27/2024 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 7,455 | $1.7M | 11/27/2024 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 6,062 | $1.0M | 11/24/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 10,963 | $0 | 11/24/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 3,435 | $0 | 3/31/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 12,439 | $0 | 3/31/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,334 | $0 | 3/31/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 6,890 | $0 | 3/31/2023 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 12,611 | $2.5M | 3/31/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,800 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 212 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 3,434 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 3,444 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 667 | $0 | 9/15/2022 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 5,283 | $818K | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 5,542 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 652 | $0 | 9/15/2022 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 3,424 | $530K | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Open Market | 6,000 | $996K | 3/4/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,629 | $0 | 9/15/2021 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,800 | $0 | 9/15/2021 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 212 | $0 | 9/15/2021 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 3,434 | $0 | 9/15/2021 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 4,057 | $732K | 9/15/2021 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 4,885 | $0 | 9/15/2021 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 2,803 | $506K | 9/15/2021 | View on chart |
| SPHR | ▲ Buy | Option Exercise | 1,629 | $0 | 9/15/2021 | View on chart |
| SPHR | ▲ Buy | Option Exercise | 1,800 | $0 | 9/15/2021 | View on chart |
| SPHR | ▲ Buy | Option Exercise | 219 | $0 | 9/15/2021 | View on chart |
| SPHR | ▲ Buy | Option Exercise | 3,861 | $0 | 9/15/2021 | View on chart |
| SPHR | ▼ Sell | Tax Withholding | 4,306 | $347K | 9/15/2021 | View on chart |
| SPHR | ▲ Buy | Option Exercise | 4,885 | $0 | 9/15/2021 | View on chart |
| SPHR | ▼ Sell | Tax Withholding | 2,803 | $226K | 9/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Knicks' role in Foot Locker's turnaround discussed
Recent coverage examines how the New York Knicks may support Foot Locker's efforts to improve its business performance. This is relevant to Madison Square Garden Sports Corp. because the Knicks are a major asset within the MSGS portfolio. While the news focuses on a partner's strategy, it highlights the broader commercial ecosystem surrounding the team.
Knicks' role in Foot Locker's turnaround discussed. Recent coverage examines how the New York Knicks may support Foot Locker's efforts to improve its business performance. This is relevant to Madison Square Garden Sports Corp. because the Knicks are a major asset within the MSGS portfolio. While the news focuses on a partner's strategy, it highlights the broader commercial ecosystem surrounding the team.